Intuitive Surgical reported 23% revenue growth and $2.50 EPS, beating estimates, while Stryker fell short due to a cyberattack and charges.
Intuitive Surgical (NASDAQ:ISRG) posted Q1 2026 revenue growth of 23% and earnings per share of $2.50, surpassing the $2.11 consensus. The company’s da Vinci procedure growth guidance was lowered from 18% to roughly 15%, yet it maintained a premium valuation at 39x forward earnings.
Stryker (NYSE:SYK) reported $6.02 billion in revenue, missing the $6.33 billion estimate, with adjusted EPS of $2.60 below the $2.98 forecast. A March cyberattack and restructuring charges weighed on results, though its Mako franchise and vascular segment, boosted by the Inari deal, showed strength with 227% free cash flow growth to $415 million. CEO Kevin Lobo affirmed full-year organic growth guidance of 8.0% to 9.5%.
Stryker’s orthopedics segment saw mixed performance, with knees up 4.7%, hips rising 3.7%, and trauma and extremities expanding 9.5%. Intuitive’s da Vinci 5 adoption drove its outperformance, contrasting with Stryker’s challenges.